These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

116 related items for PubMed ID: 4017945

  • 1. Characterization of the subunit nature of nuclear estrogen receptors by chemical cross-linking and dense amino acid labeling.
    Miller MA, Mullick A, Greene GL, Katzenellenbogen BS.
    Endocrinology; 1985 Aug; 117(2):515-22. PubMed ID: 4017945
    [Abstract] [Full Text] [Related]

  • 2. Antiestrogen binding in antiestrogen growth-resistant estrogen-responsive clonal variants of MCF-7 human breast cancer cells.
    Miller MA, Lippman ME, Katzenellenbogen BS.
    Cancer Res; 1984 Nov; 44(11):5038-45. PubMed ID: 6488162
    [Abstract] [Full Text] [Related]

  • 3. Characterization of the estrogen receptor and its dynamics in MCF-7 human breast cancer cells using a covalently attaching antiestrogen.
    Monsma FJ, Katzenellenbogen BS, Miller MA, Ziegler YS, Katzenellenbogen JA.
    Endocrinology; 1984 Jul; 115(1):143-53. PubMed ID: 6734512
    [Abstract] [Full Text] [Related]

  • 4. Dynamics of estrogen receptor turnover in uterine cells in vitro and in uteri in vivo.
    Nardulli AM, Katzenellenbogen BS.
    Endocrinology; 1986 Nov; 119(5):2038-46. PubMed ID: 3533520
    [Abstract] [Full Text] [Related]

  • 5. Estrogen receptor synthesis and turnover in MCF-7 breast cancer cells measured by a density shift technique.
    Eckert RL, Mullick A, Rorke EA, Katzenellenbogen BS.
    Endocrinology; 1984 Feb; 114(2):629-37. PubMed ID: 6690295
    [Abstract] [Full Text] [Related]

  • 6. The estrogen receptor in MCF-7 cells: evidence from dense amino acid labeling for rapid turnover and a dimeric model of activated nuclear receptor.
    Scholl S, Lippman ME.
    Endocrinology; 1984 Oct; 115(4):1295-301. PubMed ID: 6479094
    [Abstract] [Full Text] [Related]

  • 7. Selection and characterization of a breast cancer cell line resistant to the antiestrogen LY 117018.
    Bronzert DA, Greene GL, Lippman ME.
    Endocrinology; 1985 Oct; 117(4):1409-17. PubMed ID: 4029083
    [Abstract] [Full Text] [Related]

  • 8. Comparison of the physicochemical properties of uterine nuclear estrogen receptors bound to estradiol or 4-hydroxytamoxifen.
    Attardi B, Happe HK.
    Endocrinology; 1986 Aug; 119(2):904-15. PubMed ID: 3732150
    [Abstract] [Full Text] [Related]

  • 9. Ketononestrol aziridine, an agonistic estrogen receptor affinity label: study of its bioactivity and estrogen receptor covalent labeling.
    Elliston JF, Zablocki JA, Katzenellenbogen BS, Katzenellenbogen JA.
    Endocrinology; 1987 Aug; 121(2):667-76. PubMed ID: 3595536
    [Abstract] [Full Text] [Related]

  • 10. Interaction of a high affinity anti-estrogen (alpha-[4-pyrrolidinoethoxy]phenyl-4-hydroxy-alpha'-nitrostilbene, CI628M) with uterine estrogen receptors.
    Katzenellenbogen BS, Pavlik EJ, Robertson DW, Katzenellenbogen JA.
    J Biol Chem; 1981 Mar 25; 256(6):2908-15. PubMed ID: 7204382
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Progesterone receptor synthesis and degradation in MCF-7 human breast cancer cells as studied by dense amino acid incorporation. Evidence for a non-hormone binding receptor precursor.
    Mullick A, Katzenellenbogen BS.
    J Biol Chem; 1986 Oct 05; 261(28):13236-46. PubMed ID: 3759961
    [Abstract] [Full Text] [Related]

  • 13. Antiestrogenic potency and binding characteristics of the triphenylethylene H1285 in MCF-7 human breast cancer cells.
    Sheen YY, Ruh TS, Mangel WF, Katzenellenbogen BS.
    Cancer Res; 1985 Sep 05; 45(9):4192-9. PubMed ID: 4040807
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Characterization of estrogen and progesterone receptors and the dissociated regulation of growth and progesterone receptor stimulation by estrogen in MDA-MB-134 human breast cancer cells.
    Reiner GC, Katzenellenbogen BS.
    Cancer Res; 1986 Mar 05; 46(3):1124-31. PubMed ID: 3943090
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Interaction of [3H] estradiol - and [3H] monohydroxytamoxifen-estrogen receptor complexes with a monoclonal antibody.
    Tate AC, DeSombre ER, Greene GL, Jensen EV, Jordan VC.
    Breast Cancer Res Treat; 1983 Mar 05; 3(3):267-77. PubMed ID: 6671136
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Estrogen receptor transformation in MCF-7 breast cancer cells: characterization by immunochemical and sedimentation analyses.
    Miller MA, Greene GL, Katzenellenbogen BS.
    Endocrinology; 1984 Jan 05; 114(1):296-8. PubMed ID: 6690275
    [Abstract] [Full Text] [Related]

  • 20. Conversion of estrogen receptor from a state with low affinity for estradiol into a state of higher affinity does not require 4S to 5S dimerization.
    Müller RE, Traish AM, Hirota T, Bercel E, Wotiz HH.
    Endocrinology; 1985 Jan 05; 116(1):337-45. PubMed ID: 2981069
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.